These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16719406)

  • 21. Tumor-targeted quantum dots can help surgeons find tumor boundaries.
    Arndt-Jovin DJ; Kantelhardt SR; Caarls W; de Vries AH; Giese A; Jovin Ast TM
    IEEE Trans Nanobioscience; 2009 Mar; 8(1):65-71. PubMed ID: 19304503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
    Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
    Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD117 expression in glial tumors.
    Cetin N; Dienel G; Gokden M
    J Neurooncol; 2005 Nov; 75(2):195-202. PubMed ID: 16132504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
    Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation and identification of tumor stem-like cells from human glioma cell line U87 after treatment of vincristine].
    Yu SC; Yi L; Zhou ZH; Yao XH; Ping YF; Bian XW
    Ai Zheng; 2007 Dec; 26(12):1388-91. PubMed ID: 18076809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):493-501. PubMed ID: 18223480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
    Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
    Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
    Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
    J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
    Welin S; Fjällskog ML; Saras J; Eriksson B; Janson ET
    Neuroendocrinology; 2006; 84(1):42-8. PubMed ID: 17047316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
    Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors.
    Hu H; Chen G; Zhang JM; Zhang WP; Zhang L; Ge QF; Yao HT; Ding W; Chen Z; Wei EQ
    Acta Pharmacol Sin; 2005 Jun; 26(6):685-90. PubMed ID: 15916734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
    Horst Mt; Brouwer E; Verwijnen S; Rodijk M; de Jong M; Hoeben R; de Leeuw B; Smitt PS
    J Gene Med; 2007 Dec; 9(12):1071-9. PubMed ID: 17902184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrastructure of capillary permeability in malignant lymphoma].
    Ochi A; Shibata S; Mori K
    No Shinkei Geka; 1989 Dec; 17(12):1139-43. PubMed ID: 2615897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.